Single dose of psilocybin treated major depressive disorder for six weeks, study findsThe researchers found that the hallucinogenic psilocybin was associated with a ‘rapid and sustained antidepressant effect.’ Alberta COVID panel chair urges federal Conservatives to weaponize his findingsPreston Manning, the former head of the Reform Party, made the pitch last week in an email sent to Conservative MPs on the same day the report from the panel he chaired was published. Just another brick in the brain? Researchers extrapolate Pink Floyd tune from brain waves. Anxiety vs. stress: The right definition will lead to better mental healthcare Identifying individuals with high stress levels is challenging since there is a lack of consensus or guideline on the best screening method to be used in family practice. Dr. Alika Lafontaine hosts new podcast The Healthcare Divide takes a hard look at healthcare inequities relating to race. First vaccine for chikungunya gets fast-track approval in the U.S. But studies continue to determine risks of adverse reactions. Much ado in the world of Lyme vaccine development Three different approaches in the pipeline. Face mask use reduces SARS-CoV-2 transmission in community settings Use of face masks in the community will be an important component of an effective response to any future respiratory threats. Polypharmacy rising among seniors with heart failure Quebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study Connecting the dots between distraction and neurodegenerative diseases Researchers at Laval University are studying our propensity for distraction in a bid to find ways to slow the progression of certain diseases. First Previous 46 47 48 49 50 Next Last
